p63, a p53 Homolog at 3q27–29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities
Open Access
- 1 September 1998
- journal article
- research article
- Published by Elsevier in Molecular Cell
- Vol. 2 (3) , 305-316
- https://doi.org/10.1016/s1097-2765(00)80275-0
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- American Cancer Society
This publication has 34 references indexed in Scilit:
- DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinomaGenes, Chromosomes and Cancer, 1998
- Lonely No More: p53 Finds Its Kin in a Tumor Suppressor HavenCell, 1997
- Changes in Biomarker Expression in the Development of Prostatic AdenocarcinomaBiotechnic & Histochemistry, 1997
- p53: puzzle and paradigm.Genes & Development, 1996
- Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumoursNature, 1996
- Tumor suppressor p53 is a direct transcriptional activator of the human bax geneCell, 1995
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- p53 Mutations in Human CancersScience, 1991
- Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53Science, 1990